At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PYPD PolyPid Ltd.
Post-Market Trading 11-21 17:38:49 EST
3.43
-0.06
-1.72%
High3.49Low3.30Vol4.77K
Open3.30D1 Closing3.49Amplitude5.44%
Mkt Cap23.34MTradable Cap10.34MTotal Shares6.80M
T/O16.15KT/O Rate0.16%Tradable Shares3.01M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
PolyPid (PYPD) Gets a Hold from Barclays
TIPRANKS  ·  11-18
PolyPid (PYPD) Gets a Hold from Barclays
Positive Indicators and Financial Stability Support Roy Buchanan’s Optimistic Outlook on PolyPid’s Stock
TIPRANKS  ·  11-14
Positive Indicators and Financial Stability Support Roy Buchanan’s Optimistic Outlook on PolyPid’s Stock
PolyPid Ltd (PYPD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
GuruFocus.com  ·  11-14
PolyPid Ltd (PYPD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
PolyPid Ltd reports results for the quarter ended September 30 - Earnings Summary
Reuters  ·  11-13
PolyPid Ltd reports results for the quarter ended September 30 - Earnings Summary
PolyPid Announces SHIELD II Trial Progress and Financials
TIPRANKS  ·  11-13
PolyPid Announces SHIELD II Trial Progress and Financials
PolyPid Q3 2024 GAAP EPS $(1.22) Misses $(0.96) Estimate; Cash On Hand $9.5M
Benzinga  ·  11-13
PolyPid Q3 2024 GAAP EPS $(1.22) Misses $(0.96) Estimate; Cash On Hand $9.5M
PolyPid Provides Corporate Update and Reports Third Quarter 2024 Financial Results
GlobeNewswire  ·  11-13
PolyPid Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Sidoti Events, LLC's Virtual November Micro-Cap Conference
ACCESSWIRE  ·  11-12
Sidoti Events, LLC's Virtual November Micro-Cap Conference
PolyPid Ltd expected to post a loss of 100 cents a share - Earnings Preview
Reuters  ·  11-11
PolyPid Ltd expected to post a loss of 100 cents a share - Earnings Preview
PolyPid Announces $8.25 Million Share Sale Plan
TIPRANKS  ·  11-09
PolyPid Announces $8.25 Million Share Sale Plan
PolyPid Ltd: Entered Into a Sales Agreement, With Oppenheimer & Co. Inc.
THOMSON REUTERS  ·  11-09
PolyPid Ltd: Entered Into a Sales Agreement, With Oppenheimer & Co. Inc.
PolyPid to Participate in the Craig-Hallum 15th Annual Alpha Select Conference
GlobeNewswire  ·  11-07
PolyPid to Participate in the Craig-Hallum 15th Annual Alpha Select Conference
Craig-Hallum bullish on PolyPid, initiates with a Buy
TIPRANKS  ·  11-04
Craig-Hallum bullish on PolyPid, initiates with a Buy
PolyPid Ltd. : Craig-Hallum Initiates Coverage With Buy Rating and Target Price $10
THOMSON REUTERS  ·  11-04
PolyPid Ltd. : Craig-Hallum Initiates Coverage With Buy Rating and Target Price $10
PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024
GlobeNewswire  ·  10-30
PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024
PolyPid announces publication in IJS on Phase 3 SHIELD I trial of D-PLEX100
TIPRANKS  ·  10-21
PolyPid announces publication in IJS on Phase 3 SHIELD I trial of D-PLEX100
PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 Shield I Trial of D-Plex₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
THOMSON REUTERS  ·  10-21
PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 Shield I Trial of D-Plex₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
GlobeNewswire  ·  10-21
PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
PolyPid Price Target Maintained With a $14.00/Share by HC Wainwright & Co.
Dow Jones  ·  10-02
PolyPid Price Target Maintained With a $14.00/Share by HC Wainwright & Co.
Buy Rating Affirmed for PolyPid on D-PLEX’s Positive Trial Milestones and Commercial Prospects
TIPRANKS  ·  10-02
Buy Rating Affirmed for PolyPid on D-PLEX’s Positive Trial Milestones and Commercial Prospects

Introduction

Company Name.
PolyPid Ltd.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--